US2011217759A1PendingUtilityA1
Strains of bacteria and pharmaceutical composition containing one or more of such strains and use of same for preventing and treating diseases associated with or caused by altered metabolism of bile acids
Est. expiryMar 11, 2016(expired)· nominal 20-yr term from priority
Inventors:Claudio De Simone
A61K 35/747A61K 31/575A61P 1/16A61P 1/00A61K 31/7016A61K 35/74C12N 1/20C12R 2001/46C12R 2001/225A61K 35/744C12N 1/205
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Strains of bacteria characterized by exhibiting: (a) a 7α-dehydroxylase activity of less than 50%, and (b) a bile acid deconjugation activity of less than 50%, and descendants, mutants and derivatives thereof preserving activities (a) and (b); and a pharmaceutical composition using one or more of such strains and use of same for preventing and treating diseases associated with or caused by an altered metabolism of bile acids.
Claims
exact text as granted — not AI-modified1 . A bacteria strain characterized by exhibiting: (a) a 7a-dehydroxylase activity of less than 50%, and (b) a bile acid deconjugation activity of less than 50%, and descendants, mutants and derivatives thereof preserving activities (a) and (b).
2 . The strain of claim 1 , which is a gram-positive bacteria strain.
3 . The strain of claim 1 , belonging to a species selected from Streptococcus thermophilus, Streptococcus faecium, and Lactobacillus bulgaricus.
4 . The strain of claim 3 , wherein the bacteria strain is Streptococcus thermophilus YS 52 deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1670.
5 . The strain of claim 3 , wherein the bacteria strain is Streptococcus thermophilus YS 46, deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1668.
6 . The strain of claim 3 , wherein the bacteria strain is Streptococcus thermophilus YS 48, deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1669.
7 . The strain of claim 3 , wherein the bacteria strain is Streptococcus faecium SF 3, deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1671.
8 . The strain of claim 3 , wherein the bacteria strain is Lactobacillus bulgaricus LB I deposited with the CNCM, Collection Nationale de Cultures de microorganismes, Institut Pasteur, under the accession number 1-1664.
9 . The strain of claim 3 , wherein the bacteria strain is Lactobacillus bulgaricus LB 3 deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1665.
10 . The strain of claim 3 , wherein the bacteria strain is Lactobacillus bulgaricus LB 7 deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1666.
11 . The strain of claim 3 , wherein the bacteria strain is Lactobacillus bulgaricus LB 77 deposited with the CNCM, Collection Nationale de Cultures de Microorganismes, Institut Pasteur, under the accession number 1-1667.
12 - 36 . (canceled)Join the waitlist — get patent alerts
Track US2011217759A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.